Century Therapeutics Stock Analysis

Century Stock Analysis Notes

About 28.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.3. Some equities with similar Price to Book (P/B) outperform the market in the long run. Century Therapeutics has Price/Earnings To Growth (PEG) ratio of 0.26. The entity recorded a loss per share of 1.61. The firm had not issued any dividends in recent years. Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania. Century Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 170 people. To learn more about Century Therapeutics call PharmD MBA at 267 817 5790 or check out https://www.centurytx.com.

Century Therapeutics Investment Alerts

Century Therapeutics Upcoming and Recent Events

Century Largest EPS Surprises

View All Earnings Estimates

Century Stock Institutional Investors

Note, although Century Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Century Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 50.22 M.

Century Profitablity

Management Efficiency

Century Therapeutics has return on total asset (ROA) of (0.2367) % which means that it has lost $0.2367 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7314) %, meaning that it created substantial loss on money invested by shareholders. Century Therapeutics' management efficiency ratios could be used to measure how well Century Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of March 25, 2025, Return On Tangible Assets is expected to decline to -0.42. In addition to that, Return On Capital Employed is expected to decline to -0.65. At present, Century Therapeutics' Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.14, whereas Total Assets are forecasted to decline to about 343.8 M.

Technical Drivers

As of the 25th of March, Century Therapeutics shows the Standard Deviation of 3.86, mean deviation of 2.94, and Risk Adjusted Performance of (0.22). Century Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Century Therapeutics Price Movement Analysis

Century Therapeutics Insider Trading Activities

Century Therapeutics Outstanding Bonds

Century Therapeutics Predictive Daily Indicators

Century Therapeutics Forecast Models

Century Therapeutics' time-series forecasting models are one of many Century Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Century Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Century Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Century shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Century Therapeutics. By using and applying Century Stock analysis, traders can create a robust methodology for identifying Century entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Century analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Century analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Century Therapeutics stock analysis indicators help investors evaluate how Century Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Century Therapeutics shares will generate the highest return on investment. By understating and applying Century Therapeutics stock analysis, traders can identify Century Therapeutics position entry and exit signals to maximize returns.

When running Century Therapeutics' price analysis, check to measure Century Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Century Therapeutics is operating at the current time. Most of Century Therapeutics' value examination focuses on studying past and present price action to predict the probability of Century Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Century Therapeutics' price. Additionally, you may evaluate how the addition of Century Therapeutics to your portfolios can decrease your overall portfolio volatility.